EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Androgen Receptor in Laryngeal Carcinoma: Could There Be an Androgen-Refractory Tumor?

Anastasios K Goulioumis, John Varakis, Panos Goumas, Helen Papadaki

ISRN Oncology · 2011

DOI: 10.5402/2011/180518 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ISRN Oncology, 2011. Verfasst von Anastasios K Goulioumis und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, School of Medicine, University of Patras, Terpsitheas 61, 26442 Patras, Greece. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Androgen receptors (ARs) which are implicated in the pathogenesis of several malignancies can also be a possible downstream effector in laryngeal cancer. In the present study, 97 invasive squamous laryngeal carcinomas were studied by immunohistochemistry for protein expression of AR. Androgen receptors were expressed in 52.6% of tumor specimens, suggesting their implication in the pathogenesis of this tumor. Our study's aim was to investigate the hypothetical scenario of an androgen refractory laryngeal carcinoma where androgen receptors can be activated by nodal molecules in the course of an Epithelial-to-mesenchymal transition (EMT) phenomenon. In line with this we correlated AR expression with the expression of ILK, p-Akt, E-cadherin, β-catenin in our sample as well as with tumor grade and TNM stage. A reverse correlation between nuclear AR and cytoplasmic ILK expression was evidenced, indicating an interaction of those molecules in laryngeal carcinoma. Finally in our material, in those carcinomas that were expressing ARs, stronger nuclear expression of the receptor was characterized by poorer cell differentiation and correlated with the acquisition of EMT features like E-cadherin loss and β-catenin translocation raising a question whether activated ARs can drive an EMT procedure.

Autor:innen und Institutionen

  • Department of Anatomy, School of Medicine, University of Patras, Terpsitheas 61, 26442 Patras, Greece.

Zitieren

APA

Goulioumis, A. K., Varakis, J., Goumas, P., & Papadaki, H. (2011). Androgen Receptor in Laryngeal Carcinoma: Could There Be an Androgen-Refractory Tumor?. ISRN Oncology. https://doi.org/10.5402/2011/180518

Vancouver

Goulioumis AK, Varakis J, Goumas P, Papadaki H. Androgen Receptor in Laryngeal Carcinoma: Could There Be an Androgen-Refractory Tumor?. ISRN Oncology. 2011. doi:10.5402/2011/180518

BibTeX
@article{Goulioumis2011,
  author = {Goulioumis, Anastasios K and Varakis, John and Goumas, Panos and Papadaki, Helen},
  title = {Androgen Receptor in Laryngeal Carcinoma: Could There Be an Androgen-Refractory Tumor?},
  journal = {ISRN Oncology},
  year = {2011},
  doi = {10.5402/2011/180518}
}
Kostenlos starten →